Who are you and what do you want from this WG?

groups » Disease Characterisation Open Working Group » Who are you and what do you want from this WG?

• Nodar Kipshidze 21 Jul 2020

  Hello everyone! My name is Nodar Kipshidze. I work for a biotechnology start-up as the lead for our clinical affairs team. I also have a Masters in Public Health, with training and prior experience in infectious disease epidemiology (specifically: Zika Virus, HIV/AIDS, and Ebola). I am experienced in designing many epidemiological and clinical studies/trials in a variety of settings, developing both the study design and biostatistical aspects of said studies. Finally, in my current role our company has pivoted our technology as a possible therapy for COVID-19, in which I have already exhausted what research is available in the many aspects of SARS-CoV-2 and COVID-19. I am so excited to join this workgroup and look forward to helping in any way I can for this very important public health work!

• ABBAS ABEL ANZAKU 7 Jul 2020

  Hi everyone! My name is Abbas Abel Anzaku. I'm a program Officer from the Department of Clinical Laboratory Services at the Institute of Human virology, Nigeria. I'm also the laboratory focal personnel for a project that aimed at evaluating the exposure of health care workers to latent TB infection in HIV care and treatment centers in North Central Nigeria. We operate a biobank that has achieved international accreditation where collaboration is build across African scientists. I have professional interest in infectious diseases and antimicrobial resistance. During this period of infectious disease outbreaks, it is critical to join the disease characterization working group to enable me build collaboration with well experienced scientists to collectively work towards proffering a lasting solution to emerging and reemerging infectious diseases. I am highly privileged!

• ABBAS ABEL ANZAKU 7 Jul 2020

  Hi everyone! My name is Abbas Abel Anzaku. I'm a program Officer from the Department of Clinical Laboratory Services at the Institute of Human virology, Nigeria. I'm also the laboratory focal personnel for a project that aimed at evaluating the exposure of health care workers to latent TB infection in HIV care and treatment centers in North Central Nigeria. We operate a biobank that has achieved international accreditation where collaboration is build across African scientist

• jesmin_70 2 Jul 2020

  Hello,
  I am Shahanaz Chowdhury, Associate Professor & Head, Dept. of Community Medicine, Faculty of Public Health, Bangladesh University of Health Sciences. I am also member secretary of the Ethical Review Committee of Bangladesh University of Health Sciences. I feel that this platform will enable me to learn more by working with global researchers. I am always very enthusiastic to learn and gain knowledge and I hope this platform will enable me to work together for the betterment of my research knowledge and serve my country.

• SUZANNAH Lant 1 Jul 2020

  Hello, I am a clinical research fellow at the University of Liverpool, UK. I work on brain infections and neurological diseases. My recent work has been on Zika virus, and now COVID-19. I am really interested in participating in this group and seeing if we can collaborate on the characterisation of neurological disease in COVID-19 in this working group.
  Best wishes,
  Suzannah

• anjorin 28 Jun 2020

  My name is AbdulAzeez Anjorin, a young faculty member in the Department of Microbiology with over a decade experience in virology research, teaching and community service at the Lagos State University, Nigeria. I am a trained fellow on Molecular virology from the Luxembourg Institute of Health and a certified health professional in infectious disease surveillance by the International Society for Infectious Disease (ProMED-EpiCore). I hold a PhD in Medical Microbiology with expertise in medical virology and research focus on respiratory tract viruses including influenza virus. I am the team lead, influenza and other respiratory tract viruses (IORTV) research. My research group is currently working on comorbidities of SARS-CoV-2 with other respiratory tract viruses in Lagos. The Disease Characterisation Open Working Group is expected to be a valuable tool to our laboratory in terms of technical support, grant application for research funding and joint publication. We are also very much interested in future collaboration for cutting-edge research.

• Sadia Zia 25 Jun 2020

  I am Sadia Zia. I am from Pakistan. this platform is best opportunity to collaborate and work together for COVID-19 pandemic. thank you all moderators for bringing us here. it is important for low income countries to take suggestions to develop strategies for work efficiently in limited resources.